Kardigan
2 known investors
Kardigan develops targeted cardiovascular treatments through a discovery and translational research platform, with a pipeline of late-stage drug candidates aimed at functional cures for cardiovascular disease. The company integrates AI and real-world data to advance clinical development across multiple underserved cardiovascular conditions.
AI & Machine LearningBiotechHealthtechMedical Devices
Investors · 2
In the news
- Kardigan Planning for $350 Million IPO Raise: Report | PharmExecpharmexec.com · 2026
- How Kardigan spun deal leftovers into a $400M IPO | BioPharma Divebiopharmadive.com · 2026
- Kardigan closes IPO, raises $460M | KARD Stock Newsstocktitan.net · 2026
- Heart Health Biotech Kardigan Raises $400 Million in Upsized IPO - Bloombergbloomberg.com · 2026
- Kardigan Raises $254M in Series B Fundingfinsmes.com · 2025
- Kardigan - 2026 Funding Rounds & List of Investors - Tracxntracxn.com · 2025